search
Back to results

Victus Versus Conventional

Primary Purpose

Cataract

Status
Unknown status
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
Victus
Conventional Phaco
Sponsored by
Matthias Bolz
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cataract focused on measuring Victus, lensfragmentation, femtosecond laser assisted, capsulotomy,, manual, continuous curvilinear capsulorhexis (CCC), effective phaco time, phaco

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 18 years
  • related cataract
  • Ability to follow instructions from the treatment team
  • Both eyes to receive surgery

Exclusion Criteria:

  • Narrow pupils (in ther. mydriasis <6mm)
  • Narrow orbits
  • Sunken eyes
  • manifest glaucoma treated with anti-glaucomatous therapy or prior surgery
  • Conditions that pose a high risk of complications during surgery
  • Known sensitivity to planned concomitant medications
  • Patients with disorders of the ocular muscle, such as nystagmus or strabismus
  • Patients who are blind on one eye
  • Acute or chronic systemic and/or ocular illnesses that are clinically significant and will increase the risk to the subject or confound the outcomes of this study, such as but not restricted to diabetes mellitus, autoimmune/rheumatic or connective tissue diseases, dementia or epilepsy.
  • Patients who are pregnant or nursing
  • Patients who do not give informed consent

Sites / Locations

  • AKh LinzRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Victus Group

Conventional Group

Arm Description

The anterior capsulotomy and lens fragmentation will be performed by means of femtosecond laser surgery

The Conventional Group acts as a control group where the capsulotomy as well as the lens fragmentation is performed manually

Outcomes

Primary Outcome Measures

Effective Phaco Time
EPT of the conventional cataract surgery (mesured intraoperativ = Visit 2) is smaller or equal to the EPT of the Laser-assisted cataract surgery (meausred intraoperativ = Visit 2)

Secondary Outcome Measures

IOL overlap
The difference in the IOL overlap between group A and B. The IOL overlap, ΔROverlap, is the euclidian distance between the center of mass of the capsulotomy and the center of mass of the IOL, representing the symmetry of the IOL-Capsulotomy aperture- overlap
IOL Centration
The difference in the IOL centration between group A and B. The IOL centration is the euclidian distance between the center of mass of the IOL and the center of mass of the dilated pupil

Full Information

First Posted
November 18, 2013
Last Updated
January 20, 2014
Sponsor
Matthias Bolz
Collaborators
Technolas Perfect Vision GmbH
search

1. Study Identification

Unique Protocol Identification Number
NCT01991717
Brief Title
Victus Versus Conventional
Official Title
An Open-label Investigator-masked Study Comparing Femtosecond Laser Assisted With Conventional Phacoemulsification Cataract Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
January 2014
Overall Recruitment Status
Unknown status
Study Start Date
December 2013 (undefined)
Primary Completion Date
January 2015 (Anticipated)
Study Completion Date
January 2015 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Matthias Bolz
Collaborators
Technolas Perfect Vision GmbH

4. Oversight

5. Study Description

Brief Summary
Cataract surgery is among the world's most frequently performed operations. It involves removal of an opaque lens from the human eye and implantation of an artificial lens. The operation is performed under local anaesthesia using ultrasound technology, by which the lens is emulsified and removed by suction. Femtosecond laser-assisted cataract surgery is a new innovative surgical procedure that can improve the quality of cataract surgery and provide a new best possible standard of quality. In contrast to the conventional method the capsulotomy and the fragemntation are fully automatically performed with a femtosecond laser. In addition, the lens is fragmented by the laser, which substantially facilitates its removal and reduces the operation time. Study to investigate whether the femtosecond laser cataract surgery causes any significant differences in clinical outcomes as compared to the conventional, manual continuous curvilinear capsulorhexis (CCC). Effective phako time (EPT) is defined as duration of phakoemulsifikation of the crystalline lens. EPT of conventional surgery at intraoperative visit > EPT oflaser-assisted surgery at intraoperative visit

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract
Keywords
Victus, lensfragmentation, femtosecond laser assisted, capsulotomy,, manual, continuous curvilinear capsulorhexis (CCC), effective phaco time, phaco

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Victus Group
Arm Type
Experimental
Arm Description
The anterior capsulotomy and lens fragmentation will be performed by means of femtosecond laser surgery
Arm Title
Conventional Group
Arm Type
Other
Arm Description
The Conventional Group acts as a control group where the capsulotomy as well as the lens fragmentation is performed manually
Intervention Type
Device
Intervention Name(s)
Victus
Intervention Description
The anterior capsulotomy and lens fragmentation will be performed by means of femtosecond laser surgery
Intervention Type
Device
Intervention Name(s)
Conventional Phaco
Intervention Description
The capsulotomy as well as the lens fragmentation is performed manually.
Primary Outcome Measure Information:
Title
Effective Phaco Time
Description
EPT of the conventional cataract surgery (mesured intraoperativ = Visit 2) is smaller or equal to the EPT of the Laser-assisted cataract surgery (meausred intraoperativ = Visit 2)
Time Frame
surgery day
Secondary Outcome Measure Information:
Title
IOL overlap
Description
The difference in the IOL overlap between group A and B. The IOL overlap, ΔROverlap, is the euclidian distance between the center of mass of the capsulotomy and the center of mass of the IOL, representing the symmetry of the IOL-Capsulotomy aperture- overlap
Time Frame
1 month, 3 and 6 months
Title
IOL Centration
Description
The difference in the IOL centration between group A and B. The IOL centration is the euclidian distance between the center of mass of the IOL and the center of mass of the dilated pupil
Time Frame
1 month, 3 and 6 months
Other Pre-specified Outcome Measures:
Title
patients subjective perception
Description
Patients' subjective perceptions of the two operative procedures
Time Frame
1 day
Title
cornea, retina
Description
Effects of the surgical techniques on the cornea and retina as assessed by optical coherence tomography, endothelial cell count or Pentacam.
Time Frame
1 month, 3 and 6 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 18 years related cataract Ability to follow instructions from the treatment team Both eyes to receive surgery Exclusion Criteria: Narrow pupils (in ther. mydriasis <6mm) Narrow orbits Sunken eyes manifest glaucoma treated with anti-glaucomatous therapy or prior surgery Conditions that pose a high risk of complications during surgery Known sensitivity to planned concomitant medications Patients with disorders of the ocular muscle, such as nystagmus or strabismus Patients who are blind on one eye Acute or chronic systemic and/or ocular illnesses that are clinically significant and will increase the risk to the subject or confound the outcomes of this study, such as but not restricted to diabetes mellitus, autoimmune/rheumatic or connective tissue diseases, dementia or epilepsy. Patients who are pregnant or nursing Patients who do not give informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Matthias Bolz, MD
Phone
+43 (0)732 7806
Ext
1310
Email
Matthias.Bolz@akh.linz.at
First Name & Middle Initial & Last Name or Official Title & Degree
Martin Dirisamer
Phone
+43 (0)732 7806
Ext
1310
Email
martin.dirisamer@akh.linz.at
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Matthias Bolz, MD
Organizational Affiliation
AKh Linz, Ophthalmology
Official's Role
Principal Investigator
Facility Information:
Facility Name
AKh Linz
City
Linz
State/Province
Oberösterreich
ZIP/Postal Code
4021
Country
Austria
Individual Site Status
Recruiting

12. IPD Sharing Statement

Learn more about this trial

Victus Versus Conventional

We'll reach out to this number within 24 hrs